左西孟旦是作为一种钙增敏剂还是磷酸二酯酶3抑制剂发挥作用？：对奥斯特维克等人文章的评论，《英国药理学期刊》171: 5169 - 5181。
Does levosimendan act as a Ca sensitizer or PDE3 inhibitor?: Commentary on Orstavik et al., Br J Pharmacol 171: 5169-5181.
作者信息
Endoh Masao
机构信息
Department of Pharmacology, Yamagata University School of Medicine, Yamagata, Japan.
出版信息
Br J Pharmacol. 2015 Sep;172(18):4594-4596. doi: 10.1111/bph.12649.
Abstract
This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J-B, and Qvigstad E (2014). PDE3-inhibition by levosimendan is sufficient to account for its inotropic effect in failing human heart . Br J Pharmacol 171: 5169-5181. doi: 10.1111/bph.12647.
摘要
本文是对奥尔斯塔维克·O、阿塔·SH、里斯·J、达尔·CP、安徒生·GO、利维·FO、斯科梅达尔·T、奥斯内斯·J - B和奎夫斯塔德·E（2014年）所著《左西孟旦对磷酸二酯酶3的抑制足以解释其对衰竭人类心脏的正性肌力作用》一文的评论。《英国药理学期刊》171: 5169 - 5181。doi: 10.1111/bph.12647 。
相似文献
1
Does levosimendan act as a Ca sensitizer or PDE3 inhibitor?: Commentary on Orstavik et al., Br J Pharmacol 171: 5169-5181.左西孟旦是作为一种钙增敏剂还是磷酸二酯酶3抑制剂发挥作用？：对奥斯特维克等人文章的评论，《英国药理学期刊》171: 5169 - 5181。
Br J Pharmacol. 2015 Sep;172(18):4594-4596. doi: 10.1111/bph.12649.
2
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.左西孟旦对磷酸二酯酶-3的抑制作用足以解释其对衰竭人类心脏的正性肌力作用。
Br J Pharmacol. 2014 Dec;171(23):5169-81. doi: 10.1111/bph.12647.
3
The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium.左西孟旦的活性代谢物OR-1896的正性肌力作用是通过抑制大鼠心室心肌中的磷酸二酯酶3（PDE3）介导的。
PLoS One. 2015 Mar 4;10(3):e0115547. doi: 10.1371/journal.pone.0115547. eCollection 2015.
4
Modification of levosimendan-induced suppression of atrial natriuretic peptide secretion in hypertrophied rat atria.肥厚大鼠心房利伐沙班诱导的心房利钠肽分泌抑制的修饰。
Eur J Pharmacol. 2018 Jun 15;829:54-62. doi: 10.1016/j.ejphar.2018.04.006. Epub 2018 Apr 10.
5
6
Cardiovascular effects of levosimendan during rewarming from hypothermia in rat.左西孟旦对大鼠低温复温过程中心血管系统的影响。
Cryobiology. 2014 Dec;69(3):402-10. doi: 10.1016/j.cryobiol.2014.09.007. Epub 2014 Sep 30.
7
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.环磷酸腺苷磷酸二酯酶抑制作用以及收缩蛋白对钙的敏感性增加在匹莫苯丹对衰竭人心肌正性肌力作用中的贡献。
Circ Res. 1991 Mar;68(3):689-701. doi: 10.1161/01.res.68.3.689.
8
Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.磷酸二酯酶并不限制β1 - 肾上腺素能受体介导的窦性心动过速：兔中PDE3和PDE4以及大鼠中PDE1 - 5的证据。
Naunyn Schmiedebergs Arch Pharmacol. 2009 Nov;380(5):421-30. doi: 10.1007/s00210-009-0445-5. Epub 2009 Aug 20.
9
5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.5-羟色胺4（5-HT4）引发的正性肌力反应由环磷酸腺苷（cAMP）介导，并受磷酸二酯酶3（PDE3）调节，存在于衰竭的大鼠和人类心室中。
Br J Pharmacol. 2008 Dec;155(7):1005-14. doi: 10.1038/bjp.2008.339. Epub 2008 Sep 1.
10
Absence of mitochondrial activation during levosimendan inotropic action in perfused paced guinea pig hearts as demonstrated by modular control analysis.在灌注起搏豚鼠心脏中，左西孟旦正性肌力作用期间线粒体激活缺失，通过模块化控制分析证明。
Am J Physiol Regul Integr Comp Physiol. 2010 Sep;299(3):R786-92. doi: 10.1152/ajpregu.00184.2010. Epub 2010 Jun 30.
引用本文的文献
1
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.左西孟旦增加了分离的人左心房中磷蛋白磷酸化状态。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Apr;396(4):669-682. doi: 10.1007/s00210-022-02348-7. Epub 2022 Nov 29.
本文引用的文献
1
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.左西孟旦对磷酸二酯酶-3的抑制作用足以解释其对衰竭人类心脏的正性肌力作用。
Br J Pharmacol. 2014 Dec;171(23):5169-81. doi: 10.1111/bph.12647.
2
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.心肌肌球蛋白激活剂奥马环素甲磺酸盐对收缩性心力衰竭患者心功能的影响：一项双盲、安慰剂对照、交叉、剂量范围的 2 期临床试验。
Lancet. 2011 Aug 20;378(9792):676-83. doi: 10.1016/S0140-6736(11)61126-4.
3
Cardiac Ca2+ signaling and Ca2+ sensitizers.心脏钙信号与钙敏化剂
Circ J. 2008 Dec;72(12):1915-25. doi: 10.1253/circj.cj-08-0838. Epub 2008 Nov 4.
4
Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation.由肌钙蛋白突变引起的扩张型心肌病的基因敲入小鼠模型。
Circ Res. 2007 Jul 20;101(2):185-94. doi: 10.1161/CIRCRESAHA.106.146670. Epub 2007 Jun 7.
5
Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium.左西孟旦在装有水母发光蛋白的犬心室心肌正常和酸中毒条件下对肌丝Ca2+敏感性的双重调节
Br J Pharmacol. 2005 Aug;145(8):1143-52. doi: 10.1038/sj.bjp.0706292.
6
Effects of OR-1896, a metabolite of levosimendan, on force of contraction and Ca2+ transients under acidotic condition in aequorin-loaded canine ventricular myocardium.左西孟旦的代谢产物OR-1896对水母发光蛋白标记的犬心室肌在酸中毒条件下收缩力和Ca2+瞬变的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):440-8. doi: 10.1007/s00210-002-0627-x. Epub 2002 Sep 17.
7
Mechanisms of action of novel cardiotonic agents.新型强心剂的作用机制。
J Cardiovasc Pharmacol. 2002 Sep;40(3):323-38. doi: 10.1097/00005344-200209000-00001.
8
Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.左西孟旦对兔水母发光蛋白负载的右心室乳头肌和indo-1负载的单个心室心肌细胞中心肌收缩力和Ca2+瞬变的影响。
J Mol Cell Cardiol. 1998 Jun;30(6):1115-28. doi: 10.1006/jmcc.1998.0677.
9
Regulation of myocardial contractility by a downstream mechanism.
Circ Res. 1998 Jul 27;83(2):230-2. doi: 10.1161/01.res.83.2.230.
10
Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan.心肌肌钙蛋白C作为新型钙增敏药物左西孟旦的靶蛋白。
J Mol Cell Cardiol. 1995 Sep;27(9):1859-66. doi: 10.1016/0022-2828(95)90009-8.
Zotero 插件